Drakaki, A., Call, J. A., Chandana, S. R., Ahnert, J. R., El-Khoueiry, A. B., Rasco, D. W., Garmezy, B., Li, G., Zhang, S., Chen, Y., Fong, A., Challita-Eid, P. M., Li, H., Guo, Y. (2025). Preliminary results from a first-in-human phase 1 dose escalation trial of ADRX-0706, a next generation Nectin-4 ADC, in subjects with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3018